Monday, September 27, 2021

What Makes Moderna Inc’s (MRNA) Vaccine Stand Out Among Others?

The latest test results for COVID-19, a vaccine manufactured by biotech company Moderna Inc. (MRNA), were announced late last year. The most important piece of information was the high success rate even after three months following the second dose.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


A key indicator affecting the dynamics of the pandemic and decisions of the regulatory authorities to introduce or remove certain restrictions is the effective and long-lasting duration of the COVID-19 vaccine. A study published by Moderna in December last year found that antibody levels in people who receive a second dose of the vaccine remain elevated three months after vaccination. This level appears to be higher than that observed in patients with the disease at the same time.


A Backdoor Way To Profit From Today’s Crypto Bull Market

Even if you’re not actively in crypto, you deserve to know what’s actually going on...

Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.

Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .

Sponsored


Thus, Moderna’s development has been proven to be highly efficient. Pfizer, whose vaccine is currently supplied to European countries to be immunized, doesn’t provide the same data. Moderna has thereby gained an important competitive advantage. For most health care systems, exposure to the vaccine for a longer period is preferable because it will result in better protection for the population and more acceptable vaccination regimens without excessive overload. Vaccine manufacturers use this metric as well, as it allows them adequate time to manufacture sufficient amounts of vaccine to meet orders.

Moderna Inc. (MRNA) has a tentative procurement agreement for more than $11 billion worth of vaccines for 2021 which has FDA approval for use in emergencies. A 12-month efficacy study of the Moderna vaccine is not yet available since trials began in March 2020.

Investors now have less uncertainty regarding the Moderna Inc. (MRNA) COVID-19 vaccine’s effectiveness. Although there are numerous developments in biotechnology, investing in biotech is still risky. As a company in this respect, Moderna remains a classic biotech company.

Latest news

What Led The Viper Networks (VPER) Stock To Increase 16% On Friday?

At the previous close, Viper Networks Inc was soaring at $0.0150 as it gained 16.28%. There were 103.98M shares traded for VPER stock...

Has IPIX Stock Risen Last Session For A Reason?

Innovation Pharmaceuticals Inc recorded a gain of 14.67 percent to $0.2626 at the previous close. Volume in IPIX stock was 2.34M compared to...

What Caused Valiant Eagle (PSRU) Stock to Skyrocket Last session rising 91%?

The shares of Valiant Eagle, Inc. (OTCPink: PSRU) ended the day up 91.55 percent at $0.0136, and have been fluctuating in price between $0.0138...

PagerDuty Inc. (PD) Generates $67.5 Million Revenue in Q2

Cloud software provider PagerDuty Inc. (NYSE: PD) released its second-quarter report last week. The company beat Wall Street predictions in terms of revenue and...

Related news

What Led The Viper Networks (VPER) Stock To Increase 16% On Friday?

At the previous close, Viper Networks Inc was soaring at $0.0150 as it gained 16.28%. There were 103.98M shares traded for VPER stock...

Has IPIX Stock Risen Last Session For A Reason?

Innovation Pharmaceuticals Inc recorded a gain of 14.67 percent to $0.2626 at the previous close. Volume in IPIX stock was 2.34M compared to...

What Caused Valiant Eagle (PSRU) Stock to Skyrocket Last session rising 91%?

The shares of Valiant Eagle, Inc. (OTCPink: PSRU) ended the day up 91.55 percent at $0.0136, and have been fluctuating in price between $0.0138...

PagerDuty Inc. (PD) Generates $67.5 Million Revenue in Q2

Cloud software provider PagerDuty Inc. (NYSE: PD) released its second-quarter report last week. The company beat Wall Street predictions in terms of revenue and...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

1745

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam